John David Finley - 06 Nov 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
CEO, CFO, Director, Director
Signature
/s/ JD Finley
Issuer symbol
PALI
Transactions as of
06 Nov 2023
Net transactions value
$0
Form type
4
Filing time
08 Nov 2023, 17:01:03 UTC
Previous filing
05 Oct 2023
Next filing
24 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +3,475 +7.8% $0.000000 47,781 06 Nov 2023 Direct F1
holding PALI Common Stock, par value $0.01 777 06 Nov 2023 By FCW Investments, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Options Exercise -3,475 -10% 31,275 06 Nov 2023 Common Stock 3,475 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units.
F2 Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
F3 This restricted stock unit was granted on February 6, 2023, and 3,475 restricted stock units subject to the award vested on November 6, 2023, and an additional 31,275 restricted stock units will vest in equal installments over the remaining three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.
F4 Each restricted stock unit represents the right to receive, at settlement, one share of common stock.